Position
CITIGROUP INC in Sutro Biopharma, Inc.
Back to the book · All holders of STRO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $13.9K$11.57 → $24.91
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.04K | $12.1K | — | — | — | 0.0% |
| Q1 2026 | 18.8K | $469.4K | $24.91 | $13.9K | $443.4K | 0.0% |